My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 200

    1.

    A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis.

    Wei W, Zhang LL, Xu JH, Xiao F, Bao CD, Ni LQ, Li XF, Wu YQ, Sun LY, Zhang RH, Sun BL, Xu SQ, Liu S, Zhang W, Shen J, Liu HX, Wang RC.

    Arthritis Res Ther. 2009;11(6):R180. Epub 2009 Dec 1.

    PMID:
    19951408
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.

    Zhang LL, Wei W, Xiao F, Xu JH, Bao CD, Ni LQ, Li XF.

    Arthritis Rheum. 2008 Jul 15;59(7):905-10.

    PMID:
    18576295
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    3.

    A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.

    Lan JL, Chou SJ, Chen DY, Chen YH, Hsieh TY, Young M Jr.

    J Formos Med Assoc. 2004 Aug;103(8):618-23.

    PMID:
    15340661
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.

    Emery P, Fleischmann RM, Moreland LW, Hsia EC, Strusberg I, Durez P, Nash P, Amante EJ, Churchill M, Park W, Pons-Estel BA, Doyle MK, Visvanathan S, Xu W, Rahman MU.

    Arthritis Rheum. 2009 Aug;60(8):2272-83. Erratum in: Arthritis Rheum. 2010 Oct;62(10):3005.

    PMID:
    19644849
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    5.

    [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].

    Huang F, Zhang FC, Bao CD, Tao Y, Gu JR, Xu JH, Zhu P, Xu HJ, Zhang ZY, Zhao DB, Wu DH.

    Zhonghua Nei Ke Za Zhi. 2009 Nov;48(11):916-21. Chinese.

    PMID:
    20079321
    [PubMed - in process]

    Related citations

    6.

    A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis.

    Lerndal T, Svensson B.

    Rheumatology (Oxford). 2000 Mar;39(3):316-20.

    PMID:
    10788542
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    7.

    Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial.

    Furuzawa-Carballeda J, Fenutria-Ausmequet R, Gil-Espinosa V, Lozano-Soto F, Teliz-Meneses MA, Romero-Trejo C, Alcocer-Varela J.

    Clin Exp Rheumatol. 2006 Sep-Oct;24(5):514-20.

    PMID:
    17181919
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.

    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.

    Arthritis Rheum. 2004 Feb;50(2):364-71.

    PMID:
    14872477
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    9.

    Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.

    Schiff M, Keiserman M, Codding C, Songcharoen S, Berman A, Nayiager S, Saldate C, Li T, Aranda R, Becker JC, Lin C, Cornet PL, Dougados M.

    Ann Rheum Dis. 2008 Aug;67(8):1096-103. Epub 2007 Nov 29.

    PMID:
    18055472
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    10.

    Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial.

    Furuzawa-Carballeda J, Cabral AR, Zapata-Zuñiga M, Alcocer-Varela J.

    J Rheumatol. 2003 Feb;30(2):256-9.

    PMID:
    12563677
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.

    Song YW, Lee EY, Koh EM, Cha HS, Yoo B, Lee CK, Baek HJ, Kim HA, Suh YI, Kang SW, Lee YJ, Jung HG.

    Clin Ther. 2007 May;29(5):862-73.

    PMID:
    17697905
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.

    Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D.

    Arthritis Rheum. 2002 Mar;46(3):614-24.

    PMID:
    11920396
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    13.

    Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.

    Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE, Lipsky PE; ATTRACT Study Group.

    Arthritis Rheum. 2005 Apr;52(4):1020-30.

    PMID:
    15818697
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    14.

    Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.

    Lü LJ, Teng JL, Bao CD, Han XH, Sun LY, Xu JH, Li XF, Wu HX.

    Chin Med J (Engl). 2008 Apr 5;121(7):615-9.

    PMID:
    18466681
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    15.

    Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis.

    Furst DE, Venkatraman MM, McGann M, Manohar PR, Booth-LaForce C, Sarin R, Sekar PG, Raveendran KG, Mahapatra A, Gopinath J, Kumar PR.

    J Clin Rheumatol. 2011 Jun;17(4):185-92. Erratum in: J Clin Rheumatol. 2011 Oct;27(7):407.

    PMID:
    21617554
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.

    Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.

    Arthritis Rheum. 2002 Aug;46(8):2020-8.

    PMID:
    12209503
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    17.

    Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

    Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.

    Clin Ther. 2003 Jun;25(6):1700-21.

    PMID:
    12860493
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.

    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P.

    Arthritis Rheum. 2005 Jan;52(1):27-35.

    PMID:
    15641102
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    19.

    Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.

    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.

    Arthritis Rheum. 2001 Sep;44(9):1984-92.

    PMID:
    11592358
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    20.

    Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.

    Cohen SB, Cheng TT, Chindalore V, Damjanov N, Burgos-Vargas R, Delora P, Zimany K, Travers H, Caulfield JP.

    Arthritis Rheum. 2009 Feb;60(2):335-44.

    PMID:
    19180516
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk